{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:14:16Z","timestamp":1794266056753,"version":"4.9.0"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Chem"],"DOI":"10.1038\/s41570-026-00807-w","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:02:06Z","timestamp":1773680526000},"page":"258-276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Enhancing the targeting ability of metal\u2013organic frameworks in cancer therapy and diagnosis"],"prefix":"10.1038","volume":"10","author":[{"given":"Peihong","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4095-2191","authenticated-orcid":false,"given":"Tony D.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0384-9128","authenticated-orcid":false,"given":"Mingle","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"807_CR1","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1039\/C4CS90059F","volume":"43","author":"S Kitagawa","year":"2014","unstructured":"Kitagawa, S. Metal\u2013organic frameworks (MOFs). Chem. Soc. Rev. 43, 5415\u20135418 (2014).","journal-title":"Chem. Soc. Rev."},{"key":"807_CR2","doi-asserted-by":"publisher","first-page":"8819","DOI":"10.1002\/adma.201601133","volume":"28","author":"B Li","year":"2016","unstructured":"Li, B. et al. Emerging multifunctional metal\u2013organic framework materials. Adv. Mater. 28, 8819\u20138860 (2016).","journal-title":"Adv. Mater."},{"key":"807_CR3","doi-asserted-by":"publisher","first-page":"12098","DOI":"10.1039\/D1CC05157A","volume":"57","author":"P-H Tong","year":"2021","unstructured":"Tong, P.-H. et al. Metal\u2013organic frameworks (MOFs) as host materials for the enhanced delivery of biomacromolecular therapeutics. Chem. Commun. 57, 12098\u201312110 (2021).","journal-title":"Chem. Commun."},{"key":"807_CR4","doi-asserted-by":"publisher","first-page":"1606134","DOI":"10.1002\/adma.201606134","volume":"29","author":"MX Wu","year":"2017","unstructured":"Wu, M. X. & Yang, Y. W. Metal\u2013organic framework (MOF)-based drug\/cargo delivery and cancer therapy. Adv. Mater. 29, 1606134 (2017).","journal-title":"Adv. Mater."},{"key":"807_CR5","doi-asserted-by":"publisher","first-page":"214216","DOI":"10.1016\/j.ccr.2021.214216","volume":"449","author":"X Huang","year":"2021","unstructured":"Huang, X. et al. Advances in metal\u2013organic framework-based nanozymes and their applications. Coord. Chem. Rev. 449, 214216 (2021).","journal-title":"Coord. Chem. Rev."},{"key":"807_CR6","doi-asserted-by":"publisher","first-page":"216381","DOI":"10.1016\/j.ccr.2024.216381","volume":"526","author":"P-H Tong","year":"2025","unstructured":"Tong, P.-H. et al. Metal\u2013organic frameworks (MOFs) for phototherapy and synergistic phototherapy of cancer. Coord. Chem. Rev. 526, 216381 (2025).","journal-title":"Coord. Chem. Rev."},{"key":"807_CR7","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1021\/cr200324t","volume":"112","author":"LE Kreno","year":"2012","unstructured":"Kreno, L. E. et al. Metal\u2013organic framework materials as chemical sensors. Chem. Rev. 112, 1105\u20131125 (2012).","journal-title":"Chem. Rev."},{"key":"807_CR8","doi-asserted-by":"publisher","first-page":"15320","DOI":"10.1002\/ange.202006402","volume":"133","author":"LT Zhang","year":"2021","unstructured":"Zhang, L. T., Zhou, Y. & Han, S. T. The role of metal\u2013organic frameworks in electronic sensors. Angew. Chem. Int. Ed. 133, 15320\u201315340 (2021).","journal-title":"Angew. Chem. Int. Ed."},{"key":"807_CR9","doi-asserted-by":"publisher","first-page":"6802","DOI":"10.1039\/D3TB00505D","volume":"11","author":"D Luo","year":"2023","unstructured":"Luo, D. et al. Metal\u2013organic frameworks (MOFs) as apt luminescent probes for the detection of biochemical analytes. J. Mater. Chem. B 11, 6802\u20136822 (2023).","journal-title":"J. Mater. Chem. B"},{"key":"807_CR10","doi-asserted-by":"publisher","first-page":"2308589","DOI":"10.1002\/adfm.202308589","volume":"34","author":"A Wang","year":"2024","unstructured":"Wang, A. et al. Biomedical metal\u2013organic framework materials: perspectives and challenges. Adv. Funct. Mater. 34, 2308589 (2024).","journal-title":"Adv. Funct. Mater."},{"key":"807_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jconrel.2016.11.015","volume":"244","author":"F Danhier","year":"2016","unstructured":"Danhier, F. To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine? J. Control. Rel. 244, 108\u2013121 (2016).","journal-title":"J. Control. Rel."},{"key":"807_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.medj.2022.12.001","volume":"4","author":"P Zhang","year":"2023","unstructured":"Zhang, P. et al. Cancer nanomedicine toward clinical translation: obstacles, opportunities, and future prospects. Med 4, 147\u2013167 (2023).","journal-title":"Med"},{"key":"807_CR13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/jpm11080771","volume":"11","author":"J Wu","year":"2021","unstructured":"Wu, J. The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application. J. Pers. Med. 11, 771 (2021).","journal-title":"J. Pers. Med."},{"key":"807_CR14","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.addr.2008.08.005","volume":"60","author":"JD Byrne","year":"2008","unstructured":"Byrne, J. D., Betancourt, T. & Brannon-Peppas, L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Deliv. Rev. 60, 1615\u20131626 (2008).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"807_CR15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00432-014-1767-3","volume":"141","author":"R Bazak","year":"2015","unstructured":"Bazak, R., Houri, M., El Achy, S., Kamel, S. & Refaat, T. Cancer active targeting by nanoparticles: a comprehensive review of literature. J. Cancer Res. Clin. 141, 769\u2013784 (2015).","journal-title":"J. Cancer Res. Clin."},{"key":"807_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s43246-024-00475-7","volume":"5","author":"RS Forgan","year":"2024","unstructured":"Forgan, R. S. Reproducibility in research into metal\u2013organic frameworks in nanomedicine. Commun. Mater. 5, 46 (2024).","journal-title":"Commun. Mater."},{"key":"807_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s43586-024-00320-8","volume":"4","author":"I Ab\u00e1nades L\u00e1zaro","year":"2024","unstructured":"Ab\u00e1nades L\u00e1zaro, I. et al. Metal\u2013organic frameworks for biological applications. Nat. Rev. Methods Primers 4, 42 (2024).","journal-title":"Nat. Rev. Methods Primers"},{"key":"807_CR18","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1021\/acs.bioconjchem.8b00592","volume":"29","author":"MA Morales","year":"2018","unstructured":"Morales, M. A. & Halpern, J. M. Guide to selecting a biorecognition element for biosensors. Bioconjug. Chem. 29, 3231\u20133239 (2018).","journal-title":"Bioconjug. Chem."},{"key":"807_CR19","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1039\/b802258p","volume":"38","author":"Z Wang","year":"2009","unstructured":"Wang, Z. & Cohen, S. M. Postsynthetic modification of metal\u2013organic frameworks. Chem. Soc. Rev. 38, 1315\u20131329 (2009).","journal-title":"Chem. Soc. Rev."},{"key":"807_CR20","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1021\/acs.accounts.9b00039","volume":"52","author":"S Begum","year":"2019","unstructured":"Begum, S., Hassan, Z., Br\u00e4se, S., W\u00f6ll, C. & Tsotsalas, M. Metal\u2013organic framework-templated biomaterials: recent progress in synthesis, functionalization, and applications. Acc. Chem. Res. 52, 1598\u20131610 (2019).","journal-title":"Acc. Chem. Res."},{"key":"807_CR21","doi-asserted-by":"publisher","first-page":"2006291","DOI":"10.1002\/adfm.202006291","volume":"31","author":"S Mandal","year":"2021","unstructured":"Mandal, S., Natarajan, S., Mani, P. & Pankajakshan, A. Post-synthetic modification of metal\u2013organic frameworks toward applications. Adv. Funct. Mater. 31, 2006291 (2021).","journal-title":"Adv. Funct. Mater."},{"key":"807_CR22","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1039\/D2CS00262K","volume":"52","author":"A Haque","year":"2023","unstructured":"Haque, A., Alenezi, K. M., Khan, M. S., Wong, W.-Y. & Raithby, P. R. Non-covalent interactions (NCIs) in \u03c0-conjugated functional materials: advances and perspectives. Chem. Soc. Rev. 52, 454\u2013472 (2023).","journal-title":"Chem. Soc. Rev."},{"key":"807_CR23","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1039\/C4CS00497C","volume":"44","author":"C Rest","year":"2015","unstructured":"Rest, C., Kandanelli, R. & Fern\u00e1ndez, G. Strategies to create hierarchical self-assembled structures via cooperative non-covalent interactions. Chem. Soc. Rev. 44, 2543\u20132572 (2015).","journal-title":"Chem. Soc. Rev."},{"key":"807_CR24","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1039\/C1CS15233E","volume":"41","author":"CD Walkey","year":"2012","unstructured":"Walkey, C. D. & Chan, W. C. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem. Soc. Rev. 41, 2780\u20132799 (2012).","journal-title":"Chem. Soc. Rev."},{"key":"807_CR25","doi-asserted-by":"publisher","first-page":"6379","DOI":"10.1039\/D3CS00302G","volume":"52","author":"J Lee","year":"2023","unstructured":"Lee, J., Lee, J., Kim, J. Y. & Kim, M. Covalent connections between metal\u2013organic frameworks and polymers including covalent organic frameworks. Chem. Soc. Rev. 52, 6379\u20136416 (2023).","journal-title":"Chem. Soc. Rev."},{"key":"807_CR26","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/met13091511","volume":"13","author":"Z-N Zhang","year":"2023","unstructured":"Zhang, Z.-N. et al. Research and application of metal\u2013organic framework in surface modification of biomaterials \u2014 a review. Metals 13, 1511 (2023).","journal-title":"Metals"},{"key":"807_CR27","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1039\/B613014N","volume":"36","author":"JE Moses","year":"2007","unstructured":"Moses, J. E. & Moorhouse, A. D. The growing applications of click chemistry. Chem. Soc. Rev. 36, 1249\u20131262 (2007).","journal-title":"Chem. Soc. Rev."},{"key":"807_CR28","doi-asserted-by":"publisher","first-page":"213892","DOI":"10.1016\/j.ccr.2021.213892","volume":"438","author":"D Kim","year":"2021","unstructured":"Kim, D., Kang, M., Ha, H., Hong, C. S. & Kim, M. Multiple functional groups in metal\u2013organic frameworks and their positional regioisomerism. Coord. Chem. Rev. 438, 213892 (2021).","journal-title":"Coord. Chem. Rev."},{"key":"807_CR29","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1039\/C1CS15055C","volume":"41","author":"FAA Paz","year":"2012","unstructured":"Paz, F. A. A. et al. Ligand design for functional metal\u2013organic frameworks. Chem. Soc. Rev. 41, 1088\u20131110 (2012).","journal-title":"Chem. Soc. Rev."},{"key":"807_CR30","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1039\/C4CC04458D","volume":"51","author":"CV McGuire","year":"2015","unstructured":"McGuire, C. V. & Forgan, R. S. The surface chemistry of metal\u2013organic frameworks. Chem. Commun. 51, 5199\u20135217 (2015).","journal-title":"Chem. Commun."},{"key":"807_CR31","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1039\/C9CS00609E","volume":"49","author":"\u00dc K\u00f6k\u00e7am-Demir","year":"2020","unstructured":"K\u00f6k\u00e7am-Demir, \u00dc et al. Coordinatively unsaturated metal sites (open metal sites) in metal\u2013organic frameworks: design and applications. Chem. Soc. Rev. 49, 2751\u20132798 (2020).","journal-title":"Chem. Soc. Rev."},{"key":"807_CR32","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/nbt1141","volume":"23","author":"AM Wu","year":"2005","unstructured":"Wu, A. M. & Senter, P. D. Arming antibodies: prospects and challenges for immunoconjugates. Nat. Biotechnol. 23, 1137\u20131146 (2005).","journal-title":"Nat. Biotechnol."},{"key":"807_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrd1957","volume":"5","author":"D Schrama","year":"2006","unstructured":"Schrama, D., Reisfeld, R. A. & Becker, J. C. Antibody targeted drugs as cancer therapeutics. Nat. Rev. Drug Discov. 5, 147\u2013159 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"807_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0968-0004(01)01790-X","volume":"26","author":"S Muyldermans","year":"2001","unstructured":"Muyldermans, S., Cambillau, C. & Wyns, L. Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains. Trends Biochem. Sci. 26, 230\u2013235 (2001).","journal-title":"Trends Biochem. Sci."},{"key":"807_CR35","doi-asserted-by":"publisher","first-page":"15790","DOI":"10.1021\/acsnano.4c02624","volume":"18","author":"JY Oh","year":"2024","unstructured":"Oh, J. Y. et al. Unveiling the power of cloaking metal\u2013organic framework platforms via supramolecular antibody conjugation. ACS Nano 18, 15790\u201315801 (2024).","journal-title":"ACS Nano"},{"key":"807_CR36","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl9330","volume":"7","author":"RC-E Hsieh","year":"2022","unstructured":"Hsieh, R. C.-E. et al. ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer. Sci. Immunol. 7, eabl9330 (2022).","journal-title":"Sci. Immunol."},{"key":"807_CR37","doi-asserted-by":"publisher","first-page":"12579","DOI":"10.1021\/jacs.0c05039","volume":"142","author":"K Ni","year":"2020","unstructured":"Ni, K. et al. Nanoscale metal\u2013organic framework co-delivers TLR-7 agonists and anti-CD47 antibodies to modulate macrophages and orchestrate cancer immunotherapy. J. Am. Chem. Soc. 142, 12579\u201312584 (2020).","journal-title":"J. Am. Chem. Soc."},{"key":"807_CR38","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41565-018-0171-6","volume":"13","author":"M Tonigold","year":"2018","unstructured":"Tonigold, M. et al. Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona. Nat. Nanotechnol. 13, 862\u2013869 (2018).","journal-title":"Nat. Nanotechnol."},{"key":"807_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/35018500","volume":"406","author":"SC Garman","year":"2000","unstructured":"Garman, S. C., Wurzburg, B. A., Tarchevskaya, S. S., Kinet, J.-P. & Jardetzky, T. S. Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc\u03b5RI\u03b1. Nature 406, 259\u2013266 (2000).","journal-title":"Nature"},{"key":"807_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/0471140864.ps0609s55","volume":"55","author":"C Rader","year":"2009","unstructured":"Rader, C. Overview on concepts and applications of Fab antibody fragments. Curr. Protoc. Protein Sci. 55, 6\u20139 (2009).","journal-title":"Curr. Protoc. Protein Sci."},{"key":"807_CR41","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","volume":"18","author":"RS Riley","year":"2019","unstructured":"Riley, R. S., June, C. H., Langer, R. & Mitchell, M. J. Delivery technologies for cancer immunotherapy. Nat. Rev. Drug Discov. 18, 175\u2013196 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"807_CR42","doi-asserted-by":"publisher","first-page":"2106607","DOI":"10.1002\/adma.202106607","volume":"34","author":"K Alt","year":"2022","unstructured":"Alt, K. et al. Self-assembly of oriented antibody-decorated metal\u2013organic framework nanocrystals for active-targeting applications. Adv. Mater. 34, 2106607 (2022).","journal-title":"Adv. Mater."},{"key":"807_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202513294","volume":"36","author":"Y Du","year":"2025","unstructured":"Du, Y. et al. Potassium-based metal-organic framework with coordination-induced electrochemiluminescence for biosensing applications. Adv. Funct. Mater. 36, e13294 (2025).","journal-title":"Adv. Funct. Mater."},{"key":"807_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.addr.2017.05.006","volume":"119","author":"A David","year":"2017","unstructured":"David, A. Peptide ligand-modified nanomedicines for targeting cells at the tumor microenvironment. Adv. Drug Deliv. Rev. 119, 120\u2013142 (2017).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"807_CR45","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1021\/cr400166n","volume":"114","author":"BP Gray","year":"2014","unstructured":"Gray, B. P. & Brown, K. C. Combinatorial peptide libraries: mining for cell-binding peptides. Chem. Rev. 114, 1020\u20131081 (2014).","journal-title":"Chem. Rev."},{"key":"807_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-016-0223-x","volume":"23","author":"C-H Wu","year":"2016","unstructured":"Wu, C.-H., Liu, I.-J., Lu, R.-M. & Wu, H.-C. Advancement and applications of peptide phage display technology in biomedical science. J. Biomed. Sci. 23, 1\u201314 (2016).","journal-title":"J. Biomed. Sci."},{"key":"807_CR47","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1126\/science.3961484","volume":"232","author":"B Merrifield","year":"1986","unstructured":"Merrifield, B. Solid phase synthesis. Science 232, 341\u2013347 (1986).","journal-title":"Science"},{"key":"807_CR48","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/molecules16010857","volume":"16","author":"P Molek","year":"2011","unstructured":"Molek, P., Strukelj, B. & Bratkovic, T. Peptide phage display as a tool for drug discovery: targeting membrane receptors. Molecules 16, 857\u2013887 (2011).","journal-title":"Molecules"},{"key":"807_CR49","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1039\/C5CS00878F","volume":"45","author":"JL Segura","year":"2016","unstructured":"Segura, J. L., Manche\u00f1o, M. J. & Zamora, F. Covalent organic frameworks based on Schiff-base chemistry: synthesis, properties and potential applications. Chem. Soc. Rev. 45, 5635\u20135671 (2016).","journal-title":"Chem. Soc. Rev."},{"key":"807_CR50","doi-asserted-by":"publisher","first-page":"112613","DOI":"10.1016\/j.bios.2020.112613","volume":"169","author":"S Wu","year":"2020","unstructured":"Wu, S. et al. Peptide-functionalized metal\u2013organic framework nanocomposite for ultrasensitive detection of secreted protein acidic and rich in cysteine with practical application. Biosens. Bioelectron. 169, 112613 (2020).","journal-title":"Biosens. Bioelectron."},{"key":"807_CR51","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.drup.2008.08.005","volume":"11","author":"IT Tai","year":"2008","unstructured":"Tai, I. T. & Tang, M. J. SPARC in cancer biology: its role in cancer progression and potential for therapy. Drug Resist. Update 11, 231\u2013246 (2008).","journal-title":"Drug Resist. Update"},{"key":"807_CR52","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/ijc.25160","volume":"127","author":"M Inoue","year":"2010","unstructured":"Inoue, M. et al. Identification of SPARC as a candidate target antigen for immunotherapy of various cancers. Int. J. Cancer 127, 1393\u20131403 (2010).","journal-title":"Int. J. Cancer"},{"key":"807_CR53","doi-asserted-by":"publisher","first-page":"1801144","DOI":"10.1002\/adhm.201801144","volume":"7","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. ZD2-engineered gold nanostar@metal-organic framework nanoprobes for T1-weighted magnetic resonance imaging and photothermal therapy specifically toward triple-negative breast cancer. Adv. Healthc. Mater. 7, 1801144 (2018).","journal-title":"Adv. Healthc. Mater."},{"key":"807_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6800","volume":"13","author":"H Javid","year":"2024","unstructured":"Javid, H. et al. RGD peptide in cancer targeting: benefits, challenges, solutions, and possible integrin\u2013RGD interactions. Cancer Med. 13, e6800 (2024).","journal-title":"Cancer Med."},{"key":"807_CR55","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1021\/bm900043e","volume":"10","author":"MD Rowe","year":"2009","unstructured":"Rowe, M. D., Thamm, D. H., Kraft, S. L. & Boyes, S. G. Polymer-modified gadolinium metal\u2013organic framework nanoparticles used as multifunctional nanomedicines for the targeted imaging and treatment of cancer. Biomacromolecules 10, 983\u2013993 (2009).","journal-title":"Biomacromolecules"},{"key":"807_CR56","doi-asserted-by":"publisher","first-page":"1800287","DOI":"10.1002\/advs.201800287","volume":"5","author":"D Wang","year":"2018","unstructured":"Wang, D. et al. In situ one-pot synthesis of MOF\u2013polydopamine hybrid nanogels with enhanced photothermal effect for targeted cancer therapy. Adv. Sci. 5, 1800287 (2018).","journal-title":"Adv. Sci."},{"key":"807_CR57","doi-asserted-by":"publisher","first-page":"2004550","DOI":"10.1002\/adfm.202004550","volume":"31","author":"Y He","year":"2021","unstructured":"He, Y. et al. Pulmonary targeting crosslinked cyclodextrin metal\u2013organic frameworks for lung cancer therapy. Adv. Funct. Mater. 31, 2004550 (2021).","journal-title":"Adv. Funct. Mater."},{"key":"807_CR58","doi-asserted-by":"publisher","first-page":"24994","DOI":"10.1021\/acsami.5c01695","volume":"17","author":"M Cedr\u00fan-Morales","year":"2025","unstructured":"Cedr\u00fan-Morales, M. et al. Clickable polymer-based coatings for modulating the interaction of metal\u2013organic framework nanocrystals with living cells. ACS Appl. Mater. Interfaces 17, 24994\u201325010 (2025).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"807_CR59","doi-asserted-by":"publisher","first-page":"9100","DOI":"10.1021\/acsnano.3c13225","volume":"18","author":"J Bao","year":"2024","unstructured":"Bao, J. et al. Coordination self-assembled AuTPyP-Cu metal\u2013organic framework nanosheets with pH\/ultrasound dual-responsiveness for synergistically triggering cuproptosis-augmented chemotherapy. ACS Nano 18, 9100\u20139113 (2024).","journal-title":"ACS Nano"},{"key":"807_CR60","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1039\/C3MH00106G","volume":"1","author":"P Del Pino","year":"2014","unstructured":"Del Pino, P. et al. Protein corona formation around nanoparticles \u2014 from the past to the future. Mater. Horiz. 1, 301\u2013313 (2014).","journal-title":"Mater. Horiz."},{"key":"807_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202300218","volume":"19","author":"JY Oh","year":"2023","unstructured":"Oh, J. Y. et al. Protein-precoated surface of metal\u2013organic framework nanoparticles for targeted delivery. Small 19, 2300218 (2023).","journal-title":"Small"},{"key":"807_CR62","doi-asserted-by":"publisher","first-page":"2302700","DOI":"10.1002\/advs.202302700","volume":"10","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Metal\u2212organic frameworks nucleated by silk fibroin and modified with tumor-targeting peptides for targeted multimodal cancer therapy. Adv. Sci. 10, 2302700 (2023).","journal-title":"Adv. Sci."},{"key":"807_CR63","doi-asserted-by":"publisher","first-page":"2402473","DOI":"10.1002\/advs.202402473","volume":"11","author":"J Huang","year":"2024","unstructured":"Huang, J. et al. Biomimetic metal\u2013organic framework gated nanoplatform for sonodynamic therapy against extensively drug resistant bacterial lung infection. Adv. Sci. 11, 2402473 (2024).","journal-title":"Adv. Sci."},{"key":"807_CR64","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jcis.2023.04.126","volume":"646","author":"M Cai","year":"2023","unstructured":"Cai, M. et al. Enhanced lysosomal escape of cell penetrating peptide-functionalized metal\u2013organic frameworks for co-delivery of survivin siRNA and oridonin. J. Colloid Interface Sci. 646, 370\u2013380 (2023).","journal-title":"J. Colloid Interface Sci."},{"key":"807_CR65","volume":"10","author":"YL Chen","year":"2025","unstructured":"Chen, Y. L. et al. Fibrin-targeting metal\u2013organic framework nanoagent for NIR-triggered photothermal thrombus ablation. Adv. Healthc. Mater. 10, e03394 (2025).","journal-title":"Adv. Healthc. Mater."},{"key":"807_CR66","doi-asserted-by":"publisher","first-page":"2210895","DOI":"10.1002\/adma.202210895","volume":"35","author":"Y Song","year":"2023","unstructured":"Song, Y. et al. A bimetallic metal\u2013organic-framework-based biomimetic nanoplatform enhances anti-leukemia immunity via synchronizing DNA demethylation and RNA hypermethylation. Adv. Mater. 35, 2210895 (2023).","journal-title":"Adv. Mater."},{"key":"807_CR67","doi-asserted-by":"publisher","first-page":"2204342","DOI":"10.1002\/adfm.202204342","volume":"32","author":"S Lei","year":"2022","unstructured":"Lei, S. et al. ALPPL2-binding peptide facilitates targeted mRNA delivery for efficient hepatocellular carcinoma gene therapy. Adv. Funct. Mater. 32, 2204342 (2022).","journal-title":"Adv. Funct. Mater."},{"key":"807_CR68","doi-asserted-by":"publisher","first-page":"2500883","DOI":"10.1002\/adma.202500883","volume":"37","author":"Q Wang","year":"2025","unstructured":"Wang, Q. et al. Peptide-oligonucleotide nanohybrids designed for precise gene therapy of rheumatoid arthritis. Adv. Mater. 37, 2500883 (2025).","journal-title":"Adv. Mater."},{"key":"807_CR69","doi-asserted-by":"publisher","first-page":"5750","DOI":"10.1021\/acsnano.4c16824","volume":"19","author":"II Cardle","year":"2025","unstructured":"Cardle, I. I., Scherer, D. R., Jensen, M. C., Pun, S. H. & Sellers, D. L. In situ bioconjugation of synthetic peptides onto universal chimeric antigen receptor T cells for targeted cancer immunotherapies. ACS Nano 19, 5750\u20135768 (2025).","journal-title":"ACS Nano"},{"key":"807_CR70","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrd.2016.199","volume":"16","author":"J Zhou","year":"2017","unstructured":"Zhou, J. & Rossi, J. Aptamers as targeted therapeutics: current potential and challenges. Nat. Rev. Drug Discov.\u00a016, 181\u2013202 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"807_CR71","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ccr.2015.02.007","volume":"292","author":"P Zhou","year":"2015","unstructured":"Zhou, P., Shi, R., Yao, J.-F., Sheng, C.-F. & Li, H. Supramolecular self-assembly of nucleotide\u2013metal coordination complexes: from simple molecules to nanomaterials. Coord. Chem. Rev. 292, 107\u2013143 (2015).","journal-title":"Coord. Chem. Rev."},{"key":"807_CR72","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1021\/ja4098862","volume":"136","author":"C He","year":"2014","unstructured":"He, C., Lu, K., Liu, D. & Lin, W. Nanoscale metal\u2013organic frameworks for the co-delivery of cisplatin and pooled siRNAs to enhance therapeutic efficacy in drug-resistant ovarian cancer cells. J. Am. Chem. Soc. 136, 5181\u20135184 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"807_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201703812","volume":"14","author":"W Ning","year":"2018","unstructured":"Ning, W. et al. Imparting designer biorecognition functionality to metal\u2013organic frameworks by a DNA-mediated surface engineering strategy. Small 14, 1703812 (2018).","journal-title":"Small"},{"key":"807_CR74","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1021\/jacs.8b12705","volume":"141","author":"S Wang","year":"2019","unstructured":"Wang, S. et al. DNA-functionalized metal\u2013organic framework nanoparticles for intracellular delivery of proteins. J. Am. Chem. Soc. 141, 2215\u20132219 (2019).","journal-title":"J. Am. Chem. Soc."},{"key":"807_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202214750","volume":"62","author":"J Zhang","year":"2023","unstructured":"Zhang, J. et al. PD-L1 aptamer-functionalized metal\u2013organic framework nanoparticles for robust photo-immunotherapy against cancer with enhanced safety. Angew. Chem. Int. Ed. 62, e202214750 (2023).","journal-title":"Angew. Chem. Int. Ed."},{"key":"807_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/srep41233","volume":"7","author":"AA Bobko","year":"2017","unstructured":"Bobko, A. A. et al. Interstitial inorganic phosphate as a tumor microenvironment marker for tumor progression. Sci. Rep. 7, 41233 (2017).","journal-title":"Sci. Rep."},{"key":"807_CR77","doi-asserted-by":"publisher","first-page":"5808","DOI":"10.1021\/acsnano.2c12313","volume":"17","author":"Y Wei","year":"2023","unstructured":"Wei, Y. et al. Bioorthogonal activation of TLR7 agonists provokes innate immunity to reinforce aptamer-based checkpoint blockade. ACS Nano 17, 5808\u20135820 (2023).","journal-title":"ACS Nano"},{"key":"807_CR78","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1021\/jacs.2c12374","volume":"145","author":"J Zhu","year":"2023","unstructured":"Zhu, J. et al. Boosting endogenous copper (I) for biologically safe and efficient bioorthogonal catalysis via self-adaptive metal\u2013organic frameworks. J. Am. Chem. Soc. 145, 1955\u20131963 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"807_CR79","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1126\/science.287.5460.2007","volume":"287","author":"E Saxon","year":"2000","unstructured":"Saxon, E. & Bertozzi, C. R. Cell surface engineering by a modified Staudinger reaction. Science 287, 2007\u20132010 (2000).","journal-title":"Science"},{"key":"807_CR80","doi-asserted-by":"publisher","first-page":"7261","DOI":"10.1021\/ja503215w","volume":"136","author":"W Morris","year":"2014","unstructured":"Morris, W., Briley, W. E., Auyeung, E., Cabezas, M. D. & Mirkin, C. A. Nucleic acid\u2013metal organic framework (MOF) nanoparticle conjugates. J. Am. Chem. Soc. 136, 7261\u20137264 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"807_CR81","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jconrel.2016.11.016","volume":"245","author":"A Jain","year":"2017","unstructured":"Jain, A. & Cheng, K. The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis. J. Control. Rel. 245, 27\u201340 (2017).","journal-title":"J. Control. Rel."},{"key":"807_CR82","doi-asserted-by":"publisher","first-page":"2100616","DOI":"10.1002\/adma.202100616","volume":"33","author":"Q Zhao","year":"2021","unstructured":"Zhao, Q. et al. Target reprogramming lysosomes of CD8+ T cells by a mineralized metal\u2013organic framework for cancer immunotherapy. Adv. Mater. 33, 2100616 (2021).","journal-title":"Adv. Mater."},{"key":"807_CR83","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.1039\/c2cs35420a","volume":"42","author":"M Marradi","year":"2013","unstructured":"Marradi, M., Chiodo, F., Garc\u00eda, I. & Penad\u00e9s, S. Glyconanoparticles as multifunctional and multimodal carbohydrate systems. Chem. Soc. Rev. 42, 4728\u20134745 (2013).","journal-title":"Chem. Soc. Rev."},{"key":"807_CR84","doi-asserted-by":"publisher","first-page":"8301","DOI":"10.1039\/C5CS00092K","volume":"44","author":"B Kang","year":"2015","unstructured":"Kang, B., Opatz, T., Landfester, K. & Wurm, F. R. Carbohydrate nanocarriers in biomedical applications: functionalization and construction. Chem. Soc. Rev. 44, 8301\u20138325 (2015).","journal-title":"Chem. Soc. Rev."},{"key":"807_CR85","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.semcancer.2019.12.004","volume":"69","author":"H Khan","year":"2021","unstructured":"Khan, H. et al. In glyco-nanoparticles: new drug delivery systems in cancer therapy. Semin. Cancer Biol. 69, 24\u201342 (2021).","journal-title":"Semin. Cancer Biol."},{"key":"807_CR86","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1021\/acs.biomac.8b00358","volume":"19","author":"K-W Huang","year":"2018","unstructured":"Huang, K.-W. et al. Galactose derivative-modified nanoparticles for efficient siRNA delivery to hepatocellular carcinoma. Biomacromolecules 19, 2330\u20132339 (2018).","journal-title":"Biomacromolecules"},{"key":"807_CR87","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1039\/D1CC06809A","volume":"58","author":"H-N Xie","year":"2022","unstructured":"Xie, H.-N. et al. Targeted delivery of maytansine to liver cancer cells via galactose-modified supramolecular two-dimensional glycomaterial. Chem. Commun. 58, 5029\u20135032 (2022).","journal-title":"Chem. Commun."},{"key":"807_CR88","doi-asserted-by":"publisher","first-page":"115988","DOI":"10.1016\/j.ejmech.2023.115988","volume":"264","author":"W Ye","year":"2024","unstructured":"Ye, W. et al. Design, synthesis and biological evaluation of the positional isomers of the galactose conjugates able to target hepatocellular carcinoma cells via ASGPR-mediated cellular uptake and cytotoxicity. Eur. J. Med. Chem. 264, 115988 (2024).","journal-title":"Eur. J. Med. Chem."},{"key":"807_CR89","doi-asserted-by":"publisher","first-page":"1706600","DOI":"10.1002\/adfm.201706600","volume":"28","author":"Z Ye","year":"2018","unstructured":"Ye, Z. et al. An integrated therapeutic delivery system for enhanced treatment of hepatocellular carcinoma. Adv. Funct. Mater. 28, 1706600 (2018).","journal-title":"Adv. Funct. Mater."},{"key":"807_CR90","doi-asserted-by":"publisher","first-page":"1910084","DOI":"10.1002\/adfm.201910084","volume":"30","author":"J Hu","year":"2020","unstructured":"Hu, J. et al. Fabrication of glyco-metal-organic frameworks for targeted interventional photodynamic\/chemotherapy for hepatocellular carcinoma through percutaneous transperitoneal puncture. Adv. Funct. Mater. 30, 1910084 (2020).","journal-title":"Adv. Funct. Mater."},{"key":"807_CR91","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1186\/s12951-025-03704-4","volume":"23","author":"A Alhussan","year":"2025","unstructured":"Alhussan, A. et al. Lipid-based nanoparticles external triggered release strategies in cancer nanomedicine. J. Nanobiotechnol. 23, 641 (2025).","journal-title":"J. Nanobiotechnol."},{"key":"807_CR92","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jconrel.2017.01.025","volume":"249","author":"Y Dou","year":"2017","unstructured":"Dou, Y., Hynynen, K. & Allen, C. To heat or not to heat: challenges with clinical translation of thermosensitive liposomes. J. Control. Rel. 249, 63\u201373 (2017).","journal-title":"J. Control. Rel."},{"key":"807_CR93","doi-asserted-by":"publisher","first-page":"101504","DOI":"10.1016\/j.jddst.2020.101504","volume":"56","author":"AH Al-Nadaf","year":"2020","unstructured":"Al-Nadaf, A. H., Dahabiyeh, L. A., Bardaweel, S., Mahmoud, N. N. & Jawarneh, S. Functionalized mesoporous silica nanoparticles by lactose and hydrophilic polymer as a hepatocellular carcinoma drug delivery system. J. Drug Deliv. Sci. Technol. 56, 101504 (2020).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"807_CR94","doi-asserted-by":"publisher","first-page":"140044","DOI":"10.1016\/j.cej.2022.140044","volume":"454","author":"P Zhang","year":"2023","unstructured":"Zhang, P. et al. Evoking and enhancing ferroptosis of cancer stem cells by a liver-targeted and metal\u2013organic framework-based drug delivery system inhibits the growth and lung metastasis of hepatocellular carcinoma. Chem. Eng. J. 454, 140044 (2023).","journal-title":"Chem. Eng. J."},{"key":"807_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202301519","volume":"19","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Lactate-responsive gene editing to synergistically enhance macrophage-mediated cancer immunotherapy. Small 19, 2301519 (2023).","journal-title":"Small"},{"key":"807_CR96","doi-asserted-by":"publisher","first-page":"23134","DOI":"10.1021\/jacs.2c10757","volume":"144","author":"F Mastrotto","year":"2022","unstructured":"Mastrotto, F. et al. Sulfation at glycopolymer side chains switches activity at the macrophage mannose receptor (CD206) in vitro and in vivo. J. Am. Chem. Soc. 144, 23134\u201323147 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"807_CR97","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax6337","volume":"12","author":"JM Jaynes","year":"2020","unstructured":"Jaynes, J. M. et al. Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses. Sci. Transl. Med. 12, eaax6337 (2020).","journal-title":"Sci. Transl. Med."},{"key":"807_CR98","doi-asserted-by":"publisher","first-page":"13862","DOI":"10.1021\/acsanm.2c01632","volume":"5","author":"F Demir Duman","year":"2022","unstructured":"Demir Duman, F., Monaco, A., Foulkes, R., Becer, C. R. & Forgan, R. S. Glycopolymer-functionalized MOF-808 nanoparticles as a cancer-targeted dual drug delivery system for carboplatin and floxuridine. ACS Appl. Nano Mater. 5, 13862\u201313873 (2022).","journal-title":"ACS Appl. Nano Mater."},{"key":"807_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119473","volume":"223","author":"Q Sun","year":"2019","unstructured":"Sun, Q. et al. Hyaluronic acid-targeted and pH-responsive drug delivery system based on metal\u2013organic frameworks for efficient antitumor therapy. Biomaterials 223, 119473 (2019).","journal-title":"Biomaterials"},{"key":"807_CR100","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1083\/jcb.122.1.257","volume":"122","author":"RJ Peach","year":"1993","unstructured":"Peach, R. J., Hollenbaugh, D., Stamenkovic, I. & Aruffo, A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol. 122, 257\u2013264 (1993).","journal-title":"J. Cell Biol."},{"key":"807_CR101","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3109\/1061186X.2015.1052072","volume":"23","author":"G Mattheolabakis","year":"2015","unstructured":"Mattheolabakis, G., Milane, L., Singh, A. & Amiji, M. M. Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine. J. Drug Target. 23, 605\u2013618 (2015).","journal-title":"J. Drug Target."},{"key":"807_CR102","doi-asserted-by":"publisher","first-page":"2300821","DOI":"10.1002\/adhm.202300821","volume":"12","author":"MM Pan","year":"2023","unstructured":"Pan, M. M. et al. Bimetallic ions functionalized metal\u2013organic-framework nanozyme for tumor microenvironment regulating and enhanced photodynamic therapy for hypoxic tumor. Adv. Healthc. Mater. 12, 2300821 (2023).","journal-title":"Adv. Healthc. Mater."},{"key":"807_CR103","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1039\/D1TB00453K","volume":"9","author":"W Liu","year":"2021","unstructured":"Liu, W. et al. Recent advances in cell membrane coated metal\u2013organic frameworks (MOFs) for tumor therapy. J. Mater. Chem. B 9, 4459\u20134474 (2021).","journal-title":"J. Mater. Chem. B"},{"key":"807_CR104","doi-asserted-by":"publisher","first-page":"1900605","DOI":"10.1002\/advs.201900605","volume":"6","author":"H Yan","year":"2019","unstructured":"Yan, H. et al. Engineering cell membrane-based nanotherapeutics to target inflammation. Adv. Sci. 6, 1900605 (2019).","journal-title":"Adv. Sci."},{"key":"807_CR105","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","volume":"20","author":"RH Fang","year":"2023","unstructured":"Fang, R. H., Gao, W. & Zhang, L. Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat. Rev. Clin. Oncol. 20, 33\u201348 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"807_CR106","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jconrel.2020.09.012","volume":"327","author":"P Dash","year":"2020","unstructured":"Dash, P., Piras, A. M. & Dash, M. Cell membrane coated nanocarriers \u2014 an efficient biomimetic platform for targeted therapy. J. Control. Rel. 327, 546\u2013570 (2020).","journal-title":"J. Control. Rel."},{"key":"807_CR107","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1021\/acsnano.2c11965","volume":"17","author":"PHD Nguyen","year":"2023","unstructured":"Nguyen, P. H. D., Jayasinghe, M. K., Le, A. H., Peng, B. & Le, M. T. Advances in drug delivery systems based on red blood cells and their membrane-derived nanoparticles. ACS Nano 17, 5187\u20135210 (2023).","journal-title":"ACS Nano"},{"key":"807_CR108","doi-asserted-by":"publisher","first-page":"2000018","DOI":"10.1002\/sstr.202000018","volume":"1","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. Drug targeting via platelet membrane-coated nanoparticles. Small Struct. 1, 2000018 (2020).","journal-title":"Small Struct."},{"key":"807_CR109","doi-asserted-by":"publisher","first-page":"2006484","DOI":"10.1002\/smll.202006484","volume":"17","author":"F Oroojalian","year":"2021","unstructured":"Oroojalian, F., Beygi, M., Baradaran, B., Mokhtarzadeh, A. & Shahbazi, M. A. Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy. Small 17, 2006484 (2021).","journal-title":"Small"},{"key":"807_CR110","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1039\/C9BM01392J","volume":"8","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery. Biomater. Sci. 8, 552\u2013568 (2020).","journal-title":"Biomater. Sci."},{"key":"807_CR111","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz6108","volume":"6","author":"J Zhuang","year":"2020","unstructured":"Zhuang, J. et al. Targeted gene silencing in vivo by platelet membrane-coated metal\u2013organic framework nanoparticles. Sci. Adv. 6, eaaz6108 (2020).","journal-title":"Sci. Adv."},{"key":"807_CR112","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1021\/acsnano.7b07720","volume":"12","author":"X Wei","year":"2018","unstructured":"Wei, X. et al. Nanoparticle functionalization with platelet membrane enables multifactored biological targeting and detection of atherosclerosis. ACS Nano 12, 109\u2013116 (2018).","journal-title":"ACS Nano"},{"key":"807_CR113","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fimmu.2015.00082","volume":"6","author":"H Hamzeh-Cognasse","year":"2015","unstructured":"Hamzeh-Cognasse, H. et al. Platelets and infections \u2014 complex interactions with bacteria. Front. Immunol. 6, 82 (2015).","journal-title":"Front. Immunol."},{"key":"807_CR114","doi-asserted-by":"publisher","first-page":"10201","DOI":"10.1021\/acsnano.8b05200","volume":"12","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Erythrocyte membrane cloaked metal\u2013organic framework nanoparticle as biomimetic nanoreactor for starvation-activated colon cancer therapy. ACS Nano 12, 10201\u201310211 (2018).","journal-title":"ACS Nano"},{"key":"807_CR115","doi-asserted-by":"publisher","DOI":"10.1002\/ange.202203115","volume":"134","author":"S Wang","year":"2022","unstructured":"Wang, S. et al. Membrane cholesterol depletion enhances enzymatic activity of cell-membrane-coated metal-organic-framework nanoparticles. Angew. Chem. Int. Ed. 134, e202203115 (2022).","journal-title":"Angew. Chem. Int. Ed."},{"key":"807_CR116","doi-asserted-by":"publisher","first-page":"215712","DOI":"10.1016\/j.ccr.2024.215712","volume":"506","author":"H Pan","year":"2024","unstructured":"Pan, H. et al. At the crossroad of nanotechnology and cancer cell membrane coating: expanding horizons with engineered nanoplatforms for advanced cancer therapy harnessing homologous tumor targeting. Coord. Chem. Rev. 506, 215712 (2024).","journal-title":"Coord. Chem. Rev."},{"key":"807_CR117","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe7174","volume":"7","author":"SK Alsaiari","year":"2021","unstructured":"Alsaiari, S. K. et al. Sustained and targeted delivery of checkpoint inhibitors by metal\u2013organic frameworks for cancer immunotherapy. Sci. Adv. 7, eabe7174 (2021).","journal-title":"Sci. Adv."},{"key":"807_CR118","doi-asserted-by":"publisher","first-page":"15564","DOI":"10.1002\/ange.202102286","volume":"133","author":"Z Liu","year":"2021","unstructured":"Liu, Z. et al. A nature-inspired metal\u2013organic framework discriminator for differential diagnosis of cancer cell subtypes. Angew. Chem. Int. Ed. 133, 15564\u201315572 (2021).","journal-title":"Angew. Chem. Int. Ed."},{"key":"807_CR119","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1021\/ar7000815","volume":"41","author":"PS Low","year":"2008","unstructured":"Low, P. S., Henne, W. A. & Doorneweerd, D. D. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc. Chem. Res. 41, 120\u2013129 (2008).","journal-title":"Acc. Chem. Res."},{"key":"807_CR120","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1517\/17425247.5.3.309","volume":"5","author":"X Zhao","year":"2008","unstructured":"Zhao, X., Li, H. & Lee, R. J. Targeted drug delivery via folate receptors. Exp. Opin. Drug Deliv. 5, 309\u2013319 (2008).","journal-title":"Exp. Opin. Drug Deliv."},{"key":"807_CR121","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1021\/acs.nanolett.3c04369","volume":"24","author":"Y Wei","year":"2024","unstructured":"Wei, Y. et al. MOFs modulate copper trafficking in tumor cells for bioorthogonal therapy. Nano Lett. 24, 1341\u20131350 (2024).","journal-title":"Nano Lett."},{"key":"807_CR122","doi-asserted-by":"publisher","first-page":"7890","DOI":"10.1002\/ange.201903475","volume":"131","author":"J Liu","year":"2019","unstructured":"Liu, J., Liu, T., Du, P., Zhang, L. & Lei, J. Metal\u2013organic framework (MOF) hybrid as a tandem catalyst for enhanced therapy against hypoxic tumor cells. Angew. Chem. Int. Ed. 131, 7890\u20137894 (2019).","journal-title":"Angew. Chem. Int. Ed."},{"key":"807_CR123","doi-asserted-by":"publisher","first-page":"10043","DOI":"10.1021\/acs.chemrev.7b00042","volume":"117","author":"J Zielonka","year":"2017","unstructured":"Zielonka, J. et al. Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications. Chem. Rev. 117, 10043\u201310120 (2017).","journal-title":"Chem. Rev."},{"key":"807_CR124","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3390\/cancers15030666","volume":"15","author":"X Cheng","year":"2023","unstructured":"Cheng, X. et al. Application prospects of triphenylphosphine-based mitochondria-targeted cancer therapy. Cancers 15, 666 (2023).","journal-title":"Cancers"},{"key":"807_CR125","doi-asserted-by":"publisher","first-page":"6987","DOI":"10.1002\/anie.201901760","volume":"58","author":"F Wang","year":"2019","unstructured":"Wang, F. et al. A biocompatible heterogeneous MOF\u2013Cu catalyst for in vivo drug synthesis in targeted subcellular organelles. Angew. Chem. Int. Ed. 58, 6987\u20136992 (2019).","journal-title":"Angew. Chem. Int. Ed."},{"key":"807_CR126","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh1736","volume":"9","author":"X Peng","year":"2023","unstructured":"Peng, X. et al. Autonomous metal\u2013organic framework nanorobots for active mitochondria-targeted cancer therapy. Sci. Adv. 9, eadh1736 (2023).","journal-title":"Sci. Adv."},{"key":"807_CR127","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/bios13080785","volume":"13","author":"L Liu","year":"2023","unstructured":"Liu, L., Ma, X., Chang, Y., Guo, H. & Wang, W. Biosensors with boronic acid-based materials as the recognition elements and signal labels. Biosensors 13, 785 (2023).","journal-title":"Biosensors"},{"key":"807_CR128","doi-asserted-by":"publisher","first-page":"2103590","DOI":"10.1002\/smll.202103590","volume":"17","author":"J Liang","year":"2021","unstructured":"Liang, J., Liu, J., Lord, M. S., Wang, Y. & Liang, K. De Novo engineering of metal\u2013organic framework-printed in vitro diagnostic devices for specific capture and release of tumor cells. Small 17, 2103590 (2021).","journal-title":"Small"},{"key":"807_CR129","doi-asserted-by":"publisher","first-page":"2401559","DOI":"10.1002\/adma.202401559","volume":"36","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. Boronic acid-rich lanthanide metal\u2013organic frameworks enable deep proteomics with ultratrace biological samples. Adv. Mater. 36, 2401559 (2024).","journal-title":"Adv. Mater."},{"key":"807_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99407-5","volume":"11","author":"M Fytory","year":"2021","unstructured":"Fytory, M. et al. Dual-ligated metal\u2013organic framework as novel multifunctional nanovehicle for targeted drug delivery for hepatic cancer treatment. Sci. Rep. 11, 19808 (2021).","journal-title":"Sci. Rep."},{"key":"807_CR131","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jconrel.2025.01.047","volume":"379","author":"UJ Bj\u00f6rgvinsd\u00f3ttir","year":"2025","unstructured":"Bj\u00f6rgvinsd\u00f3ttir, U. J., Larsen, J. B., Bak, M., Andresen, T. L. & M\u00fcnter, R. Targeting antibodies dissociate from drug delivery liposomes during blood circulation. J. Control. Rel. 379, 982\u2013992 (2025).","journal-title":"J. Control. Rel."},{"key":"807_CR132","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41551-018-0314-y","volume":"2","author":"JP Ioannidis","year":"2018","unstructured":"Ioannidis, J. P., Kim, B. Y. & Trounson, A. How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation. Nat. Biomed. Eng. 2, 797\u2013809 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"807_CR133","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/s41565-021-01017-9","volume":"16","author":"EP Stater","year":"2021","unstructured":"Stater, E. P., Sonay, A. Y., Hart, C. & Grimm, J. The ancillary effects of nanoparticles and their implications for nanomedicine. Nat. Nanotechnol. 16, 1180\u20131194 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"807_CR134","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1039\/D1CS00918D","volume":"51","author":"R Ettlinger","year":"2022","unstructured":"Ettlinger, R. et al. Toxicity of metal\u2013organic framework nanoparticles: from essential analyses to potential applications. Chem. Soc. Rev. 51, 464\u2013484 (2022).","journal-title":"Chem. Soc. Rev."}],"container-title":["Nature Reviews Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41570-026-00807-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41570-026-00807-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41570-026-00807-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:02:48Z","timestamp":1776081768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41570-026-00807-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":134,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["807"],"URL":"https:\/\/doi.org\/10.1038\/s41570-026-00807-w","relation":{},"ISSN":["2397-3358"],"issn-type":[{"value":"2397-3358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"6 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}